Stock listing

OTC:AONC American Oncology Network, Inc. Stock

Follow American Oncology Network, Inc. into a list and get an email when it puts out news.

Share price · OTC:AONC

$22.03 USD -0.97 (-4.2%)

Close on Oct 30, 2026

Past year +138.4% · daily closes, Oct 30, 2025 – Oct 30, 2026, adjusted for splits
Day range
$22.03 – $22.03 USDOct 30, 2026
Volume
101 sharesOct 30, 2026
Market cap
$644.3M USDAt the close on Oct 30, 2026 · price × 29.25M shares outstanding
52-week range
$0.0004 – $25.00 USDLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
Traded on an average day
$17,907 USDMedian day 0 shares · 35 days with no trades · last 3 months, Jul 30, 2026 – Oct 30, 2026
American Oncology Network, Inc. logo

Daily closes

Last 3 months, Jul 30, 2026 – Oct 30, 2026 · OTC:AONC · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$22.03-0.97-4.2%$22.03$22.03$22.03101
$23.00+2.20+10.6%$20.50$23.00$20.502,137
$20.80-1.21-5.5%$20.80$20.80$20.80466
$22.01+0.010.0%$22.93$22.93$22.01800
$22.00+1.00+4.8%$21.00$25.00$21.006,400
$21.00+13.00+162.5%$8.00$21.03$8.0040,200
$8.00-3.00-27.3%$8.00$8.00$8.00100
$11.000.000.0%$11.00$11.00$11.000
$11.000.000.0%$11.00$11.00$11.000
$11.000.000.0%$11.00$11.00$11.000
$11.000.000.0%$11.00$11.00$11.00100
$11.000.000.0%$11.00$11.00$11.000
$11.000.000.0%$11.00$11.00$11.000
$11.000.000.0%$11.00$11.00$11.00100
$11.000.000.0%$11.00$11.00$11.00100
$11.000.000.0%$11.00$11.00$11.000
$11.000.000.0%$11.00$11.00$11.000
$11.00+1.00+10.0%$11.00$11.00$11.00100
$10.000.000.0%$10.00$10.00$10.00100
$10.000.000.0%$10.00$10.00$10.000
$10.00-1.00-9.1%$10.00$10.00$10.00400
$11.000.000.0%$11.00$11.00$11.000
$11.000.000.0%$11.00$11.00$11.000
$11.000.000.0%$11.00$11.00$11.000
$11.000.000.0%$11.00$11.00$11.000
$11.000.000.0%$11.00$11.00$11.000
$11.000.000.0%$11.00$11.00$11.000
$11.000.000.0%$11.00$11.00$11.00100
$11.000.000.0%$11.00$11.00$11.00100
$11.000.000.0%$11.00$11.00$11.000
$11.000.000.0%$11.00$11.00$11.000
$11.00+1.01+10.1%$11.00$11.00$11.00100
$9.990.000.0%$9.99$9.99$9.990
$9.990.000.0%$9.99$9.99$9.990
$9.990.000.0%$9.99$9.99$0.00101,200
$9.990.000.0%$9.99$9.99$9.990
$9.99-0.01-0.1%$9.99$9.99$9.99100
$10.000.000.0%$10.00$10.00$10.000
$10.000.000.0%$10.00$10.00$10.000
$10.00-3.00-23.1%$10.00$10.00$10.00100
$13.000.000.0%$13.00$13.00$13.000
$13.000.000.0%$13.00$13.00$13.000
$13.00+3.01+30.1%$13.00$13.00$13.00100
$9.99-2.01-16.8%$9.99$9.99$9.99100
$12.000.000.0%$12.00$12.00$12.000
$12.00+0.88+7.9%$12.00$12.00$12.00100
$11.120.000.0%$11.12$11.12$11.120
$11.120.000.0%$11.12$11.12$11.120
$11.120.000.0%$11.12$11.12$11.120
$11.12-1.08-8.9%$11.12$11.12$11.12100
$12.200.000.0%$12.20$12.20$12.200
$12.20+2.21+22.1%$12.20$12.20$12.20200
$9.990.000.0%$9.99$9.99$9.990
$9.99-0.01-0.1%$9.99$9.99$7.001,000
$10.000.000.0%$10.00$10.00$10.000
$10.000.000.0%$10.00$10.00$10.000
$10.000.000.0%$10.00$10.00$10.000
$10.000.000.0%$10.00$10.00$10.000
$10.000.000.0%$10.00$10.00$10.000
$10.000.000.0%$10.00$10.00$10.00100
$10.000.000.0%$10.00$10.00$10.000
$10.00-2.00-16.7%$10.00$10.00$10.00100
Ticker
OTC:AONC
Asset type
Stock
Sector
Health care
Industry
Health care services
Exchange
OTC
Currency
USD

American Oncology Network, Inc. on 6ix

Sector
Health care
Industry
Health care services
Calls
3 calls with a replay · 3 with a transcript · latest May 16, 2024
Decks
2 decks · latest Sep 29, 2023

Valuation

price Oct 30, 2026

Enterprise value
No statements on 6ix yet
P/E
No statements on 6ix yet
EV/sales
No statements on 6ix yet
EV/EBITDA
No statements on 6ix yet
Price/book
No statements on 6ix yet
Gross margin
No statements on 6ix yet
Operating margin
No statements on 6ix yet
Net margin
No statements on 6ix yet
Debt to equity
No statements on 6ix yet
Beta vs S&P 500
-0.24

Health care services: the 10 companies nearest in size, of 419 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
American Oncology Network, Inc. · OTC:AONCUS$644.3Mn/an/an/an/an/an/an/a-0.24
Phreesia, Inc. · NYSE:PHRUS$708.2MUS$634.7M67.8×1.3×12.8×1.9×2.1%0.0×0.42
Jinxin Fertility Group Ltd. · HKEX:1951US$692.4MUS$1.02Bn/a2.6×12.6×0.5×−36.9%0.3×n/a
Xunfei Healthcare Technology Co., Ltd. · HKEX:2506US$681.9MUS$664.6Mn/a4.8×n/a5.3×−7.1%0.1×n/a
Fulgent Genetics, Inc. · NASDAQ:FLGTUS$673.9MUS$381.6Mn/a1.2×n/a0.7×−27.5%0.0×0.99
Bright Eye Hospital Group Co., Ltd. Class A · SZSE:301239US$669.8MUS$635.8M60.6×1.4×n/a2.1×2.4%0.1×n/a
Shanghai Runda Medical Technology Co., Ltd. Class A · SSE:603108US$661.9MUS$589.8Mn/a0.6×n/a1.2×−8.6%0.1×n/a
PT Metro Healthcare Indonesia Tbk · IDX:CAREUS$648.2MUS$680.5M1,733×21.8×n/a3.9×1.2%0.5×n/a
Wuxi Commercial Mansion Grand Orient Co., Ltd. Class A · SSE:600327US$640.0MUS$570.9Mn/a1.5×n/a1.6×−11.5%0.0×n/a
Ramkhamhaeng Hospital Public Co. Ltd. · SET:RAMUS$625.4MUS$905.1M7.7×1.5×8.4×0.9×13.5%0.5×n/a
WELL Health Technologies Corp. · TSX:WELLUS$606.6MUS$1.09Bn/a1.0×7.9×1.1×−8.3%1.1×1.08
Median of the othersUS$665.8MUS$650.2M64.2×1.4×10.5×1.4×−7.7%0.1×0.99

Team and board

Officers

OfficerRole
Todd SchonherzCHIEF EXECUTIVE OFFICER
David AfsharCHIEF FINANCIAL & OPERATING OFFICER
Ella S. FriedmanPRESIDENT NETWORK OPERATIONS
Charles Charlie GoddardGENERAL COUNSEL
Puneeth IndurlalEXECUTIVE VICE PRESIDENT OF STRATEGIC OPERATIONS & ENTERPRISE SOLUTIONS
Steve SwartEXECUTIVE VICE PRESIDENT PRACTICE OPERATIONS
Alti RahmanCHIEF STRATEGY & INNOVATION OFFICER
Anthony BelottCHIEF DEVELOPMENT OFFICER
James GilmoreCHIEF PHARMACY & CLINICAL SERVICES OFFICER
Joe VerschleiserCHIEF GROWTH & PERFORMANCE OFFICER
Karen PilleyCHIEF REVENUE CYCLE OFFICER
Kristin MatisziwCHIEF COMPLIANCE & RISK OFFICER
Mark MochCHIEF INFORMATION OFFICER
Stephen Fred DiversCHIEF MEDICAL OFFICER
Tena MesserCHIEF CLINICAL OFFICER
Terri CaseyCHIEF HUMAN RESOURCES OFFICER

Board

DirectorRole
Antonio MoranBOARD MEMBER
Asit JhaBOARD MEMBER
Bradley M. FluegelBOARD MEMBER
Bradley T. SumrallBOARD MEMBER
Christopher ChayBOARD MEMBER
Daniel SpitzBOARD MEMBER
Daniel T. MiltonBOARD MEMBER
Farn ChanBOARD MEMBER
James StithBOARD MEMBER
Jay SidloskiBOARD MEMBER
Jeanna L. KnobleBOARD MEMBER
Jiantao DingBOARD MEMBER
Jose AlemarBOARD MEMBER
Joseph Z. YeBOARD MEMBER
Luis T. CamposBOARD MEMBER
Martin PalmeriBOARD MEMBER
Michael J. CastineBOARD MEMBER
Praveen KolliparaBOARD MEMBER
Raja S. MehdiBOARD MEMBER
Ralph V. BocciaBOARD MEMBER
Ram S. TrehanBOARD MEMBER
Rangappa RajendraBOARD MEMBER
Ravi SarinBOARD MEMBER
Sakeer HussainBOARD MEMBER
Sam MikhailBOARD MEMBER
Sreekanth C. ReddyBOARD MEMBER
Stephen Fred DiversCHIEF MEDICAL OFFICER
Taral PatelBOARD MEMBER
Todd SchonherzCHIEF EXECUTIVE OFFICER
William Bill J. ValleBOARD MEMBER

Events

Results days

QuarterResultsShare move
Q4 2024Mar 27, 2025−5.3%
Q4 2022Mar 31, 2023+0.7%
Q3 2022Nov 14, 2022−0.2%
Q2 2022Aug 12, 2022+0.1%
Q1 2022Apr 13, 2022+0.2%
Q3 2021Nov 22, 2021+0.6%
Q2 2021Aug 24, 2021
Q1 2021May 27, 2021

Open Events

Decks

DeckKindSlidesDate
Investor Presentation (September 2023)Investor deck29 slidesSep 29, 2023
Digital Transformation Opportunities — SPAC Merger (October 2022)SPAC merger26 slidesOct 6, 2022

Open Decks

Financials

Annual, in USD

Income statement

LineFY2024FY2023FY2022FY2021FY2020FY2019
Revenue1.76B1.28B1.15B943.7M724.7M
Cost of revenue1.64B1.20B1.05B865.8M658.6M
Gross profit117.8M82.8M95.5M78.0M66.1M
Selling, general and administrative133.9M100.7M86.6M77.0M44.0M
Operating income-17.4M-49.2M5.57M911.0K22.1M
Depreciation and amortization19.4M16.7M17.1M6.08M3.66M1.01M
EBITDA1.94M-32.4M22.6M6.99M25.7M
Interest expense7.06M6.42M3.42M1.42M1.12M
Income before tax-24.5M-62.5M2.59M355.0K21.2M
Income tax2.50M384.0K1.03B460.0K-783.0K-245.0K
Net income-3.97M-5.54M2.59M-105.0K22.0M
Earnings per share, basic-0.29-0.830.06-0.000.74

Balance sheet

LineFY2024FY2023FY2022FY2021FY2020
Cash and equivalents62.8M28.5M26.9M27.4M25.0K
Short-term investments9.79M35.4M9.85M0
Receivables189.6M165.0M166.1M138.1M97.9M
Inventory60.7M44.6M36.5M34.5M22.1M
Current assets331.5M277.8M242.0M208.3M25.0K
Property, plant and equipment75.7M32.6M28.7M
Goodwill10.9M1.05M
Total assets470.3M374.5M326.2M248.3M49.0K
Accounts payable170.7M127.6M106.5M92.9M70.3M
Current liabilities216.8M169.0M140.9M119.3M24.9K
Long-term debt87.1M80.6M80.3M63.7M
Total debt147.4M128.3M127.1M63.7M
Total liabilities362.3M303.7M264.2M22.3M24.9K
Shareholders' equity18.8M-161.7M62.0M312.6M24.2K
Shares outstanding13.5M6.69M41.7M41.7M29.9M

Cash flow

LineFY2024FY2023FY2022FY2021FY2020FY2019
Cash from operations-4.94M-18.1M-6.78M-1.23M37.2M-18.3M
Capital spending-21.0M-12.3M-7.19M-8.32M-12.2M-11.6M
Free cash flow-25.9M-30.4M-14.0M-34.7M25.0M-29.9M
Cash from investing-2.41M-35.4M-14.0M-333.5M-14.7M-21.2M
Cash from financing41.7M55.1M15.3M335.5M16.3M39.2M
Share buybacks-368.0K-9.57M00
Change in cash34.3M1.61M-5.43M803.3K38.8M-329.0K

Open Financials

Cap table

Built by 6ix from American Oncology Network, Inc.’s releases

Common shares
29,248,362
Fully diluted
29,248,362

Fully diluted

LineShares
Common shares29,248,362

Share count over time

CountShares
Nov 22, 202629,248,362

Open Cap table

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Bradley M. Fluegel
Other companies: Performant Financial Corporation (Director · Since at least Feb 4, 2014); NeuroMetrix Inc (Director · Jul 1, 2022 – May 22, 2024 · Past); Digital Transformation Opportunities Corp (Director · Mar 9, 2021 – Mar 9, 2021 · Past); Fitbit Inc (Director · Mar 4, 2018 – Jan 14, 2021 · Past); Walgreen Company (Senior Vice President · Oct 1, 2012 – Nov 1, 2014 · Past); Elevance Health, Inc. (EVP, Chief Strategy Officer · Nov 1, 2010 – Nov 5, 2010 · Past)
BOARD MEMBER · Since at least Sep 20, 2023
Ravi Sarin
Other companies: The Oncology Institute, Inc. (Director · Nov 12, 2021 – Mar 17, 2023 · Past)
BOARD MEMBER · Since at least Sep 20, 2023
William Bill J. Valle
Other companies: TriSalus Life Sciences, Inc. (Director · Since at least Jan 29, 2025)
BOARD MEMBER · Since at least Apr 19, 2024
Alti RahmanCHIEF STRATEGY & INNOVATION OFFICER · Since at least Nov 5, 2026
Anthony BelottCHIEF DEVELOPMENT OFFICER · Since at least Nov 5, 2026
Antonio MoranBOARD MEMBER · Since at least Nov 4, 2026
Asit JhaBOARD MEMBER · Since at least Nov 4, 2026
Bradley T. SumrallBOARD MEMBER · Since at least Nov 4, 2026
Charles Charlie GoddardGENERAL COUNSEL · Since at least Nov 5, 2026
Christopher ChayBOARD MEMBER · Since at least Nov 4, 2026
All 46 people
PersonSeat
Daniel SpitzBOARD MEMBER · Since at least Nov 4, 2026
Daniel T. MiltonBOARD MEMBER · Since at least Nov 4, 2026
David AfsharCHIEF FINANCIAL & OPERATING OFFICER · Since at least Nov 5, 2026
David H GouldChief Financial Officer · Sep 20, 2023 – Sep 20, 2023 · Past
Ella S. FriedmanPRESIDENT NETWORK OPERATIONS · Since at least Nov 5, 2026
Erica MallonGeneral Counsel · Sep 20, 2023 – Jul 16, 2024 · Past
Farn ChanBOARD MEMBER · Since at least Nov 4, 2026
James GilmoreCHIEF PHARMACY & CLINICAL SERVICES OFFICER · Since at least Nov 5, 2026
James StithBOARD MEMBER · Since at least Nov 5, 2026
Jay SidloskiBOARD MEMBER · Since at least Nov 4, 2026
Jeanna L. KnobleBOARD MEMBER · Since at least Nov 4, 2026
Jiantao DingBOARD MEMBER · Since at least Nov 4, 2026
Joe VerschleiserCHIEF GROWTH & PERFORMANCE OFFICER · Since at least Nov 4, 2026
Jose AlemarBOARD MEMBER · Since at least Nov 4, 2026
Joseph Z. YeBOARD MEMBER · Since at least Nov 4, 2026
Karen PilleyCHIEF REVENUE CYCLE OFFICER · Since at least Nov 5, 2026
Kristin MatisziwCHIEF COMPLIANCE & RISK OFFICER · Since at least Nov 5, 2026
Luis T. CamposBOARD MEMBER · Since at least Nov 4, 2026
Mark MochCHIEF INFORMATION OFFICER · Since at least Nov 5, 2026
Martin PalmeriBOARD MEMBER · Since at least Nov 4, 2026
Michael J. CastineBOARD MEMBER · Since at least Nov 4, 2026
Praveen KolliparaBOARD MEMBER · Since at least Nov 4, 2026
Puneeth IndurlalEXECUTIVE VICE PRESIDENT OF STRATEGIC OPERATIONS & ENTERPRISE SOLUTIONS · Since at least Nov 5, 2026
Raja S. MehdiBOARD MEMBER · Since at least Nov 4, 2026
Ralph V. BocciaBOARD MEMBER · Since at least Nov 4, 2026
Ram S. TrehanBOARD MEMBER · Since at least Nov 4, 2026
Rangappa RajendraBOARD MEMBER · Since at least Nov 4, 2026
Sakeer HussainBOARD MEMBER · Since at least Nov 4, 2026
Sam MikhailBOARD MEMBER · Since at least Nov 4, 2026
Sreekanth C. ReddyBOARD MEMBER · Since at least Nov 4, 2026
Stephen Fred DiversCHIEF MEDICAL OFFICER · Since at least Nov 4, 2026
Steve SwartEXECUTIVE VICE PRESIDENT PRACTICE OPERATIONS · Since at least Nov 4, 2026
Taral PatelBOARD MEMBER · Since at least Nov 4, 2026
Tena MesserCHIEF CLINICAL OFFICER · Since at least Nov 5, 2026
Terri CaseyCHIEF HUMAN RESOURCES OFFICER · Since at least Nov 5, 2026
Todd SchonherzCHIEF EXECUTIVE OFFICER · Since at least Nov 5, 2026

Open People

Log in to ask 6ix AI your own questions about American Oncology Network, Inc.